FDA Okays Marketing Of Nerve Simulation Device To Relieve IBS Pain

By Beth Wang / June 7, 2019 at 4:11 PM
FDA for the first time has granted marketing authorization to a device intended to help relieve pain in adolescents with irritable bowel syndrome (IBS) through the use of electrical nerve stimulation, the agency announced Friday (June 7). The approval comes just one week after an interagency report called for increased research on potential pain management devices , such as neuromodulation devices, which use electrical or magnetic stimulation on nervous system tissue to reduce sensitivity to pain. The device, IB-Stim, was...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.